We are a leading supplier and manufacturer of therapeutic and diagnostic radioisotopes in the field of nuclear medicine, proudly situated within the Cancer Research, Training, and Prevention Institute in Tehran, Iran.
Currently, Our primary focus lies in the production of FDG radiopharmaceuticals for cancer therapy.
With an unwavering commitment to innovation, we are passionate about pioneering advancements in the future of nuclear medicine. Our principal goal is to remain at the forefront of scientific research and development, encompassing physical, chemical, and pharmaceutical disciplines. We strive to push the boundaries of science, driving progress and excellence in our field.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Corner Of Chamran Highway, Seoul Blvd., Cancer Researches Center Hospital,iran, Islamic Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Tehran, Tehran
Nik Nahad Parto Questions
Nik Nahad Parto's LinkedIn profile is https://ir.linkedin.com/company/nik-nahad-parto
Nik Nahad Parto has
5 employees.
View email and phone details for 5
employees at Nik Nahad Parto.
Nik Nahad Parto's industry is
Pharmaceutical Manufacturing
Nik Nahad Parto's top competitors are
Resinfam Company,
Instituto De Astrofísica De Canarias (Iac),
Radiology Edge,
Simab Resin Co.,
Gelpolymers Lab,
Job Vision (جاب ویژن),
Parsisotope,
Taak Resin Kaveh,
Biosun Pharmed.
Nik Nahad Parto's categories are Pharmaceutical Manufacturing
Nik Nahad Parto's founding year is 1402
